Publication|Articles|February 6, 2024
- Pharmaceutical Commerce - February 2024
- Volume 19
- Issue 1
Pharmaceutical Commerce - February 2024 Issue (PDF)
Click the title above for a link to open the Pharmaceutical Commerce February 2024 issue in an interactive PDF format.
Advertisement
Articles in this issue
almost 2 years ago
The Value of 3PLsalmost 2 years ago
New Year, New Aspirationsalmost 2 years ago
Access Insights and Information Aboundalmost 2 years ago
A Look at the Medicare 'Extra Help' Programalmost 2 years ago
Who Moved My Prescription? Part IIalmost 2 years ago
The Path for Prescription Drug Salesalmost 2 years ago
A Pharma Pricing and Agreements Primer in Today's Complex Landscapealmost 2 years ago
The Impact of 340B on Commercial Contractsalmost 2 years ago
DSCSA 2024 or 2023 Déjà Vu?Newsletter
Stay ahead in the life sciences industry with Pharmaceutical Commerce, the latest news, trends, and strategies in drug distribution, commercialization, and market access.
Advertisement
Advertisement
Advertisement
Trending on Pharmaceutical Commerce
1
Trade & Channel Strategies 2025: The $405 Billion Patent Cliff Demands Partnership and Adaptive Market Access Strategies
2
How AI Control Towers and Digital Twins Can Restore Pharmaceutical Profit Margins
3
The Great Repricing: How Pharma Must Evolve for Three Diverging Payer Economies
4
Pharma Pulse: Amgen's Uplizna Secures CD19 Approval for Myasthenia Gravis, as Asthma Biologic Switches Highlight Efficacy Expectations Gap
5
